World News

Abu Dhabi Department of Health partners with MBZUAI, Core42 to launch Global AI Healthcare Academy

May 14, 2024

Switzerland's Nemo wins 68th Eurovision Song Contest

May 13, 2024

UN chief urges 'immediate ceasefire' in Gaza as 35,000 Palestinians killed

May 13, 2024

gypt to back genocide case against Israel at world court

May 13, 2024

Nepal's 'Everest Man' Rita climbs summit for 29th time

May 13, 2024

Donors pledge more than $2bn for Gaza

May 13, 2024

The US targets China's shipbuilding industry

May 13, 2024

More News

Signs of rift within Israel over Gaza

May 13, 2024

Jerusalem, Israel], May 13: The Israel Defense Forces (IDF) issued an order to evacuate civilians from the Jabalia refugee area in the northern Gaza Strip due to Hamas rebuilding its forces there, according to the Institute for the Study of War (ISW, USA) on May 12. . Al-Jazeera and Palestinian news agency WAFA reported that Israeli fighter jets bombed Jabalia with carpet bombs, causing many casualties, although the exact number is unknown.

Still leading the tablet market but Apple is in decline

May 13, 2024

Washington [USA], May 13: According to the above report, total shipments of the global tablet market increased slightly from 30.6 million units in the first quarter of 2023 to 30.8 million units in the first quarter of 2024. This is the first time this market has increased shipments since the second quarter of 2021 and then gradually saturated. This growth is expected to stem from the start of a new replacement cycle, although long-term volumes are unlikely to match the spike seen during the Covid-19 pandemic. However, the switch to high-end tablets is a good opportunity as consumers look for more productive devices.

AstraZeneca's troubles with its Covid-19 vaccine are not over yet

May 13, 2024

Washington [USA], may 13: The European Commission recently announced the termination of circulation of AstraZeneca 's Covid-19 Vaxzevria vaccine from May 7. Previously, according to The Conversation , AstraZeneca filed an application on March 27 to terminate the circulation license of this vaccine in European Union (EU) member countries. AstraZeneca said it will also proactively coordinate with country management agencies to terminate Vaxzevria's marketing authorization when there is no longer a need for use.